Stockscreener 앱 받기
21.69
0.60%
-0.13
시간 외 거래:
21.84
0.15
+0.69%
전일 마감가:
$21.82
열려 있는:
$21.9
하루 거래량:
43,153
Relative Volume:
1.16
시가총액:
$193.81M
수익:
$64.99M
순이익/손실:
$-4.30M
주가수익비율:
-41.71
EPS:
-0.52
순현금흐름:
$-3.51M
1주 성능:
+3.68%
1개월 성능:
-21.41%
6개월 성능:
-24.90%
1년 성능:
-38.61%
1일 변동 폭
$21.40
$22.10
1주일 범위
$20.06
$22.10
52주 변동 폭
$18.90
$38.68
Sanara Medtech Inc Stock (SMTI) Company Profile
명칭
Sanara Medtech Inc
전화
817-529-2300
주소
1200 SUMMIT AVE, FORT WORTH
SMTI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
21.69 | 194.80M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
575.34 | 201.58B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.96 | 55.30B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.73 | 38.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
256.55 | 36.71B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
280.23 | 20.27B | 2.96B | 487.70M | 344.00M | 6.6758 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2024-12-23 | 개시 | H.C. Wainwright | Buy |
| 2022-05-20 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-06-30 | 개시 | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc 주식(SMTI)의 최신 뉴스
Will Sanara MedTech Inc. stock continue upward momentumDip Buying & Verified Swing Trading Watchlist - Newser
Is Sanara MedTech Inc. stock attractive for long term wealth buildingJuly 2025 Closing Moves & Advanced Swing Trade Entry Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech, Inc. (SMTI) And Encourages Investors to Connect - ACCESS Newswire
Can Sanara MedTech Inc. stock sustain free cash flow growthMarket Volume Summary & AI Enhanced Trading Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech, Inc. (SMTI) And Encourages Stockholders to Connect - ACCESS Newswire
Sanara Medtech: A Strategic Pivot After a Steep Decline - AD HOC NEWS
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sanara MedTech, Inc. (SMTI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Trading the Move, Not the Narrative: (SMTI) Edition - news.stocktradersdaily.com
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc. (SMTI) Investors to Inquire about Securities Investigation - ACCESS Newswire
2025-11-30 | Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc. (SMTI) Investors to Inquire about Securities Investigation | NDAQ:SMTI | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech, Inc. (SMTI) And Encourages Investors to Reach Out - ACCESS Newswire
Will Sanara MedTech Inc. stock reach all time highs in 2025 - moha.gov.vn
Will Sanara MedTech Inc. stock recover faster than peersJuly 2025 Fed Impact & Weekly Market Pulse Alerts - BỘ NỘI VỤ
Sanara MedTech: Too Cheap And Better Positioned After Earlier Strategic Missteps (NASDAQ:SMTI) - Seeking Alpha
Sanara MedTech Releases 2026 Strategy Presentation - MSN
[8-K] Sanara MedTech Inc. Reports Material Event | SMTI SEC FilingForm 8-K - Stock Titan
INVESTOR ALERT: Investigation of Sanara MedTech Inc. (SMTI) Announced by Holzer & Holzer, LLC - GlobeNewswire
INVESTOR ALERT: Investigation of Sanara MedTech Inc. (SMTI) Announced by Holzer & Holzer, LLC - GlobeNewswire Inc.
Sanara MedTech Inc. (SMTI) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Sanara MedTech, Inc. Hits New 52-Week Low at $18.90 - Markets Mojo
Sanara MedTech Hits New 52-Week Low at $19.06 Amid Ongoing Struggles - Markets Mojo
Sanara MedTech Hits 52-Week Low at $19.10 Amid Ongoing Struggles - Markets Mojo
How analysts rate Sanara MedTech Inc. stock today2025 Key Highlights & Precise Buy Zone Tips - newser.com
Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - Business Wire
Sanara MedTech Inc. (SMTI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - MarketScreener
Will Sanara MedTech Inc. stock maintain dividend yieldJuly 2025 Outlook & AI Enhanced Trading Signals - newser.com
Can Sanara MedTech Inc. stock deliver consistent earnings growth2025 Retail Activity & Risk Managed Investment Signals - newser.com
Can Sanara MedTech Inc. stock sustain revenue growthMarket Trend Report & Long-Term Capital Growth Ideas - newser.com
(SMTI) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - The Globe and Mail
How strong is Sanara MedTech Inc. stock revenue growthJuly 2025 Momentum & Consistent Profit Alerts - newser.com
Can Sanara MedTech Inc. stock resist market sell offs2025 Key Lessons & Daily Volume Surge Trade Alerts - newser.com
Identifying reversal signals in Sanara MedTech Inc.Weekly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Sanara MedTech Inc. to Present at Piper Sandler 37th Annual Healthcare Conference - Quiver Quantitative
Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd - The Manila Times
Is Sanara MedTech Inc. stock gaining market shareWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Best data tools to analyze Sanara MedTech Inc. stockEarnings Summary Report & Consistent Income Trade Recommendations - newser.com
Sanara MedTech (SMTI) Price Target Decreased by 18.00% to 41.82 - MSN
Sanara MedTech Reports Strong Q3 2025 Growth - MSN
HC Wainwright Cuts Sanara MedTech (NASDAQ:SMTI) Price Target to $36.00 - Defense World
Sanara Medtech Inc (SMTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.32%
0.55%
자본화:
|
볼륨(24시간):